Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models

Molecular Aspects of Medicine

Volumn 43-44, Issue , 2015, Pages 54-65

  Sproul, Andrew A ^a,b  

^a New York Stem Cell Foundation Laboratory   (United States)

^b Department of Medicine   (United States)

Author keywords

Alzheimer's disease; Disease modeling; iPSC; Regenerative medicine; Stem cell

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ASTROCYTE; CELL FUNCTION; CELL THERAPY; CELL TRANSDIFFERENTIATION; DISEASE MODEL; DRUG DEVELOPMENT; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC PROCEDURES; GENOME EDITING; HUMAN; MICROGLIA; MOUSE MODEL; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PERSONALIZED MEDICINE; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL; CELL DIFFERENTIATION; GENETICS; INDUCED PLURIPOTENT STEM CELL; NERVE CELL; PATHOLOGY; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ALZHEIMER DISEASE; CELL DIFFERENTIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURONS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

EID: 84943361972     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2015.06.007     Document Type: Review

References (100)

1. R.R. Ager, and et al. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss Hippocampus 25 7 2015 813 826 10.1002/hipo.22405
2. M. Allgaier, and C. Allgaier An update on drug treatment options of Alzheimer's disease Front. Biosci 19 2014 1345 1354
3. N. Amariglio, and et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient PLoS Med 6 2009 e1000029 10.1371/journal.pmed.1000029
4. C. Andorfer, and et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms J. Neurochem 86 2003 582 590
5. K.H. Ashe, and K.R. Zahs Probing the biology of Alzheimer's disease in mice Neuron 66 2010 631 645 10.1016/j.neuron.2010.04.031
6. C. Ballard, and et al. Alzheimer's disease Lancet 377 2011 1019 1031 10.1016/S0140-6736(10)61349-9
7. L.M. Bekris, Yu C.E., T.D. Bird, and D.W. Tsuang Genetics of Alzheimer disease J. Geriatr. Psychiatry Neurol 23 2010 213 227 10.1177/0891988710383571
8. J. Berger-Sweeney, and et al. Selective immunolesions of cholinergic neurons in mice: effects on neuroanatomy, neurochemistry, and behavior J. Neurosci 21 2001 8164 8173
9. C. Beutner, K. Roy, B. Linnartz, I. Napoli, and H. Neumann Generation of microglial cells from mouse embryonic stem cells Nat. Protoc 5 2010 1481 1494 10.1038/nprot.2010.90
10. C.J. Bissonnette, and et al. The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells Stem Cells 29 2011 802 811 10.1002/stem.626
11. M. Blurton-Jones, and et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 106 2009 13594 13599 10.1073/pnas.0901402106
12. K.H. Campbell, J. McWhir, W.A. Ritchie, and I. Wilmut Sheep cloned by nuclear transfer from a cultured cell line Nature 380 1996 64 66 10.1038/380064a0
13. A.M. Cataldo, and et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations Am. J. Pathol 157 2000 277 286
14. J. Cedernaes, H.B. Schioth, and C. Benedict Efficacy of antibody-based therapies to treat Alzheimer's disease: just a matter of timing? Exp. Gerontol 57 2014 104 106 10.1016/j.exger.2014.05.002
15. S.M. Chambers, and et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nat. Biotechnol 27 2009 275 280 10.1038/nbt.1529
16. S. Chanda, and et al. Generation of induced neuronal cells by the single reprogramming factor ASCL1 Stem Cell Rep 3 2014 282 296 10.1016/j.stemcr.2014.05.020
17. Chen K.G., B.S. Mallon, R.D. McKay, and P.G. Robey Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics Cell Stem Cell 14 2014 13 26 10.1016/j.stem.2013.12.005
18. S.H. Choi, and et al. A three-dimensional human neural cell culture model of Alzheimer's disease Nature 515 2014 274 278 10.1038/nature13800
19. K.J. Christie, and A.M. Turnley Regulation of endogenous neural stem/progenitor cells for neural repair-factors that promote neurogenesis and gliogenesis in the normal and damaged brain Front. Cell. Neurosci 6 2012 70 10.3389/fncel.2012.00070
20. G.M. Cole, Ma Q.L., and S.A. Frautschy Omega-3 fatty acids and dementia Prostaglandins Leukot. Essent. Fatty Acids 81 2009 213 221 10.1016/j.plefa.2009.05.015
21. E.A. Copelan Hematopoietic stem-cell transplantation N. Engl. J. Med 354 2006 1813 1826 10.1056/NEJMra052638
22. L.A. Crompton, and et al. Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling Stem Cell Res 11 2013 1206 1221 10.1016/j.scr.2013.08.002
23. R.L. Davis, H. Weintraub, and A.B. Lassar Expression of a single transfected cDNA converts fibroblasts to myoblasts Cell 51 1987 987 1000
24. F.P. Di Giorgio, M.A. Carrasco, M.C. Siao, T. Maniatis, and K. Eggan Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model Nat. Neurosci 10 2007 608 614 10.1038/nn1885
25. J.T. Dimos, and et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons Science 321 2008 1218 1221 10.1126/science.1158799
26. J.A. Doudna, and E. Charpentier Genome editing. The new frontier of genome engineering with CRISPR-Cas9 Science 346 2014 1258096 10.1126/science.1258096
27. Duan L., and et al. Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death Mol. Neurodegener 9 2014 3 10.1186/1750-1326-9-3
28. M. Eiraku, and et al. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals Cell Stem Cell 3 2008 519 532 10.1016/j.stem.2008.09.002
29. G.A. Elder, M.A. Gama Sosa, and R. De Gasperi Transgenic mouse models of Alzheimer's disease Mt Sinai J. Med 77 2010 69 81 10.1002/msj.20159
30. M.J. Evans, and M.H. Kaufman Establishment in culture of pluripotential cells from mouse embryos Nature 292 1981 154 156
31. A. Farini, C. Sitzia, S. Erratico, M. Meregalli, and Y. Torrente Clinical applications of mesenchymal stem cells in chronic diseases Stem Cells Int 2014 2014 306573 10.1155/2014/306573
32. A. Fragkouli, N.V. van Wijk, R. Lopes, N. Kessaris, and V. Pachnis LIM homeodomain transcription factor-dependent specification of bipotential MGE progenitors into cholinergic and GABAergic striatal interneurons Development 136 2009 3841 3851 10.1242/dev.038083
33. S. Frantz Embryonic stem cell pioneer Geron exits field, cuts losses Nat. Biotechnol 30 2012 12 13 10.1038/nbt0112-12
34. Y. Freund-Levi, and et al. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms Int. J. Geriatr. Psychiatry 23 2008 161 169 10.1002/gps.1857
35. Guo Q., and et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice Nat. Med 5 1999 101 106 10.1038/4789
36. J. Hanna, and et al. Direct cell reprogramming is a stochastic process amenable to acceleration Nature 462 2009 595 601 10.1038/nature08592
37. S.E. Hickman, and J. El Khoury TREM2 and the neuroimmunology of Alzheimer's disease Biochem. Pharmacol 88 2014 495 498 10.1016/j.bcp.2013.11.021
38. Hu K. Vectorology and factor delivery in induced pluripotent stem cell reprogramming Stem Cells Dev 23 2014 1301 1315 10.1089/scd.2013.0621
39. Huang Y., and L. Mucke Alzheimer mechanisms and therapeutic strategies Cell 148 2012 1204 1222 10.1016/j.cell.2012.02.040
40. H. Inoue, N. Nagata, H. Kurokawa, and S. Yamanaka iPS cells: a game changer for future medicine EMBO J. 33 2014 409 417 10.1002/embj.201387098
41. M.A. Israel, and et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells Nature 482 2012 216 220 10.1038/nature10821
42. B. Johannesson, L. Sui, D.O. Freytes, R.J. Creusot, and D. Egli Toward beta cell replacement for diabetes EMBO J. 34 7 2015 841 855 10.15252/embj.201490685
43. T. Kondo, and et al. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness Cell Stem Cell 12 2013 487 496 10.1016/j.stem.2013.01.009
44. M.A. Lancaster, and et al. Cerebral organoids model human brain development and microcephaly Nature 501 2013 373 379 10.1038/nature12517
45. G.R. Langley Considering a new paradigm for Alzheimer's disease research Drug Discov. Today 19 2014 1114 1124 10.1016/j.drudis.2014.03.013
46. A.S. Lee, Tang C., Rao M.S., I.L. Weissman, and Wu J.C. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies Nat. Med 19 2013 998 1004 10.1038/nm.3267
47. Li M., K. Suzuki, N.Y. Kim, Liu G.H., and J.C. Izpisua Belmonte A cut above the rest: targeted genome editing technologies in human pluripotent stem cells J. Biol. Chem 289 2014 4594 4599 10.1074/jbc.R113.488247
48. Liang W.S., and et al. Neuronal gene expression in non-demented individuals with intermediate Alzheimer's disease neuropathology Neurobiol. Aging 31 2010 549 566 10.1016/j.neurobiolaging.2008.05.013
49. Liu Y., and et al. Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits Nat. Biotechnol 31 2013 440 447 10.1038/nbt.2565
50. G.R. Martin Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells Proc. Natl. Acad. Sci. U.S.A. 78 1981 7634 7638
51. J.D. Miller, and et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging Cell Stem Cell 13 2013 691 705 10.1016/j.stem.2013.11.006
52. S. Moore, and et al. APP metabolism regulates Tau proteostasis in human cerebral cortex neurons Cell Rep 11 2015 689 696 10.1016/j.celrep.2015.03.068
53. Mu Y., and F.H. Gage Adult hippocampal neurogenesis and its role in Alzheimer's disease Mol. Neurodegener 6 2011 85 10.1186/1750-1326-6-85
54. C.R. Muratore, and et al. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons Hum. Mol. Genet 23 2014 3523 3536 10.1093/hmg/ddu064
55. F.J. Najm, and et al. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells Nat. Biotechnol 31 2013 426 433 10.1038/nbt.2561
56. S. Noggle, and et al. Human oocytes reprogram somatic cells to a pluripotent state Nature 478 2011 70 75 10.1038/nature10397
57. J. Perez-Tur, and et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene Neuroreport 7 1995 297 301
58. U. Pfisterer, and et al. Direct conversion of human fibroblasts to dopaminergic neurons Proc. Natl. Acad. Sci. U.S.A. 108 2011 10343 10348 10.1073/pnas.1105135108
59. R.E. Pitas, J.K. Boyles, S.H. Lee, D. Foss, and R.W. Mahley Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins Biochim. Biophys. Acta 917 1987 148 161
60. K. Plucinska, and et al. Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes J. Neurosci 34 2014 10710 10728 10.1523/JNEUROSCI.0433-14.2014
61. D. Pre, and et al. A time course analysis of the electrophysiological properties of neurons differentiated from human induced pluripotent stem cells (iPSCs) PLoS ONE 9 2014 e103418 10.1371/journal.pone.0103418
62. R. Radde, C. Duma, M. Goedert, and M. Jucker The value of incomplete mouse models of Alzheimer's disease Eur. J. Nucl. Med. Mol. Imaging 35 Suppl. 1 2008 S70 S74 10.1007/s00259-007-0704-y
63. S. Reardon, and D. Cyranoski Japan stem-cell trial stirs envy Nature 513 2014 287 288 10.1038/513287a
64. K.L. Ring, and et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor Cell Stem Cell 11 2012 100 109 10.1016/j.stem.2012.05.018
65. C.A. Ross, and S.S. Akimov Human-induced pluripotent stem cells: potential for neurodegenerative diseases Hum. Mol. Genet 23 2014 R17 R26 10.1093/hmg/ddu204
66. A.D. Roth, G. Ramirez, R. Alarcon, and R. Von Bernhardi Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation Biol. Res 38 2005 381 387
67. B. Rumble, and et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease N. Engl. J. Med 320 1989 1446 1452 10.1056/NEJM198906013202203
68. C. Schwab, M. Hosokawa, and P.L. McGeer Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease Exp. Neurol 188 2004 52 64 10.1016/j.expneurol.2004.03.016
69. S.D. Schwartz, and et al. Embryonic stem cell trials for macular degeneration: a preliminary report Lancet 379 2012 713 720 10.1016/S0140-6736(12)60028-2
70. C.T. Scott, and D. Magnus Wrongful termination: lessons from the geron clinical trial Stem Cells Transl. Med 3 2014 1398 1401 10.5966/sctm.2014-0147
71. D.R. Seib, and A. Martin-Villalba Neurogenesis in the normal ageing hippocampus: a mini-review Gerontology 2014 10.1159/000368575
72. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791 10.1126/science.1074069
73. Shi Y., and et al. A human stem cell model of early Alzheimer's disease pathology in Down syndrome Sci. Transl. Med 4 2012 124ra129 10.1126/scitranslmed.3003771
74. Shi Y., P. Kirwan, and F.J. Livesey Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks Nat. Protoc 7 2012 1836 1846 10.1038/nprot.2012.116
75. E.Y. Son, and et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons Cell Stem Cell 9 2011 205 218 10.1016/j.stem.2011.07.014
76. A.A. Sproul, and et al. Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors PLoS ONE 9 2014 e84547 10.1371/journal.pone.0084547
77. A.A. Sproul, and et al. Generation of iPSC lines from archived non-cryoprotected biobanked dura mater Acta Neuropathol. Commun 2 2014 4 10.1186/2051-5960-2-4
78. M. Tachibana, and et al. Human embryonic stem cells derived by somatic cell nuclear transfer Cell 153 2013 1228 1238 10.1016/j.cell.2013.05.006
79. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676 10.1016/j.cell.2006.07.024
80. J.A. Thomson, and et al. Embryonic stem cell lines derived from human blastocysts Science 282 1998 1145 1147
81. T. Tomiyama, and et al. A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia Ann. Neurol 63 2008 377 387 10.1002/ana.21321
82. Tong L.M., and et al. Inhibitory interneuron progenitor transplantation restores normal learning and memory in ApoE4 knock-in mice without or with Abeta accumulation J. Neurosci 34 2014 9506 9515 10.1523/JNEUROSCI.0693-14.2014
83. J.Q. Trojanowski, and et al. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects Alzheimers Dement 6 2010 230 238 10.1016/j.jalz.2010.03.008
84. T. Tsuchiya, and et al. Characterization of microglia induced from mouse embryonic stem cells and their migration into the brain parenchyma J. Neuroimmunol 160 2005 210 218 10.1016/j.jneuroim.2004.10.025
85. M. Turner, and et al. Toward the development of a global induced pluripotent stem cell library Cell Stem Cell 13 2013 382 384 10.1016/j.stem.2013.08.003
86. R. Vassar, D.M. Kovacs, Yan R., and P.C. Wong The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential J. Neurosci 29 2009 12787 12794 10.1523/JNEUROSCI.3657-09.2009
87. T. Vierbuchen, and et al. Direct conversion of fibroblasts to functional neurons by defined factors Nature 463 2010 1035 1041 10.1038/nature08797
88. Wang T., S.T. Warren, and Jin P. Toward pluripotency by reprogramming: mechanisms and application Protein Cell 4 2013 820 832 10.1007/s13238-013-3074-1
89. H. Wichterle, J.M. Garcia-Verdugo, D.G. Herrera, and A. Alvarez-Buylla Young neurons from medial ganglionic eminence disperse in adult and embryonic brain Nat. Neurosci 2 1999 461 466 10.1038/8131
90. G. Woodruff, and et al. The presenilin-1 DeltaE9 mutation results in reduced gamma-secretase activity, but not total loss of PS1 function, in isogenic human stem cells Cell Rep 5 2013 974 985 10.1016/j.celrep.2013.10.018
91. T. Yagi, and et al. Modeling familial Alzheimer's disease with induced pluripotent stem cells Hum. Mol. Genet 20 2011 4530 4539 10.1093/hmg/ddr394
92. M. Yamada, and et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells Nature 510 2014 533 536 10.1038/nature13287
93. A.S. Yoo, and et al. MicroRNA-mediated conversion of human fibroblasts to neurons Nature 476 2011 228 231 10.1038/nature10323
94. Yu D.X., and et al. Modeling hippocampal neurogenesis using human pluripotent stem cells Stem Cell Rep 2 2014 295 310 10.1016/j.stemcr.2014.01.009
95. Zeng H., and et al. Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells PLoS ONE 5 2010 e11853 10.1371/journal.pone.0011853
96. Zhang B., and et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease Cell 153 2013 707 720 10.1016/j.cell.2013.03.030
97. Zhang Y., and et al. Rapid single-step induction of functional neurons from human pluripotent stem cells Neuron 78 2013 785 798 10.1016/j.neuron.2013.05.029
98. Zhang Y.W., J. Denham, and R.S. Thies Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors Stem Cells Dev 15 2006 943 952 10.1089/scd.2006.15.943
99. Zhang Y.W., R. Thompson, Zhang H., and Xu H. APP processing in Alzheimer's disease Mol. Brain 4 2011 3 10.1186/1756-6606-4-3
100. Zou Q., and et al. Direct conversion of human fibroblasts into neuronal restricted progenitors J. Biol. Chem 289 2014 5250 5260 10.1074/jbc.M113.516112